140 related articles for article (PubMed ID: 18544624)
21. Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture, and Stiffness in Primary Hyperparathyroidism.
Walker MD; Nishiyama KK; Zhou B; Cong E; Wang J; Lee JA; Kepley A; Zhang C; Guo XE; Silverberg SJ
J Clin Endocrinol Metab; 2016 Mar; 101(3):905-13. PubMed ID: 26745256
[TBL] [Abstract][Full Text] [Related]
22. Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism.
Cusano NE; Rubin MR; Silva BC; Tay YD; Williams JM; Agarwal S; Omeragic B; Guo XE; Bilezikian JP
J Clin Endocrinol Metab; 2018 Jan; 103(1):196-205. PubMed ID: 29069380
[TBL] [Abstract][Full Text] [Related]
23. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.
Stein EM; Silva BC; Boutroy S; Zhou B; Wang J; Udesky J; Zhang C; McMahon DJ; Romano M; Dworakowski E; Costa AG; Cusano N; Irani D; Cremers S; Shane E; Guo XE; Bilezikian JP
J Bone Miner Res; 2013 May; 28(5):1029-40. PubMed ID: 23225022
[TBL] [Abstract][Full Text] [Related]
24. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
[TBL] [Abstract][Full Text] [Related]
25. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
Duan Y; De Luca V; Seeman E
J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
[TBL] [Abstract][Full Text] [Related]
26. Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women.
Adami S; Gatti D; Braga V; Bianchini D; Rossini M
J Bone Miner Res; 1999 Jan; 14(1):120-4. PubMed ID: 9893073
[TBL] [Abstract][Full Text] [Related]
27. Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J
Clin Endocrinol (Oxf); 2006 Jan; 64(1):58-62. PubMed ID: 16402929
[TBL] [Abstract][Full Text] [Related]
28. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL
J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
[TBL] [Abstract][Full Text] [Related]
31. Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate.
Szymczak J; Bohdanowicz-Pawlak A
Horm Metab Res; 2013 Sep; 45(10):759-64. PubMed ID: 23888411
[TBL] [Abstract][Full Text] [Related]
32. "Trabecular Bone Score" (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism.
Romagnoli E; Cipriani C; Nofroni I; Castro C; Angelozzi M; Scarpiello A; Pepe J; Diacinti D; Piemonte S; Carnevale V; Minisola S
Bone; 2013 Mar; 53(1):154-9. PubMed ID: 23228370
[TBL] [Abstract][Full Text] [Related]
33. [Bone status after parathyroidectomy for primary hyperparathyroidism].
Yamauchi M; Sugimoto T
Clin Calcium; 2005 Dec; 15(12):11-16. PubMed ID: 16322668
[TBL] [Abstract][Full Text] [Related]
34. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
35. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.
Sankaran S; Gamble G; Bolland M; Reid IR; Grey A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1653-62. PubMed ID: 20130069
[TBL] [Abstract][Full Text] [Related]
36. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy.
Bhadada SK; Bhansali A; Ahluwalia J; Chanukya GV; Behera A; Dutta P
Clin Endocrinol (Oxf); 2009 Apr; 70(4):527-32. PubMed ID: 18727711
[TBL] [Abstract][Full Text] [Related]
37. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study.
Ardawi MS; Al-Sibiany AM; Bakhsh TM; Rouzi AA; Qari MH
Osteoporos Int; 2012 Jun; 23(6):1789-97. PubMed ID: 22041864
[TBL] [Abstract][Full Text] [Related]
38. Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture.
Hong AR; Lee JH; Kim JH; Kim SW; Shin CS
Calcif Tissue Int; 2019 Apr; 104(4):382-389. PubMed ID: 30659307
[TBL] [Abstract][Full Text] [Related]
39. Effect of rheumatoid arthritis on volumetric bone mineral density and bone geometry, assessed by peripheral quantitative computed tomography in postmenopausal women treated with bisphosphonates.
Tournis S; Samdanis V; Psarelis S; Liakou C; Antoniou J; Georgoulas T; Dontas I; Papaioannou N; Gazi S; Lyritis GP
J Rheumatol; 2012 Jun; 39(6):1215-20. PubMed ID: 22467921
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid excess affects cortical bone geometry in premenopausal, but not postmenopausal, women.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Calcif Tissue Int; 2008 Mar; 82(3):182-90. PubMed ID: 18278571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
